Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-09-14

Clinical Trial Update: A Study of Sativex® for Pain Relief of Peripheral Neuropathic Pain, Associated With Allodynia [Phase 3]

View source ↗

Summary

Phase 3 study evaluating Sativex for pain relief in peripheral neuropathic pain with allodynia has been completed; results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sativex (nabiximol)

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Pain, Peripheral Neuropathy | Phase 3 | Status: COMPLETED | Results posted: 2012-09-14